{"DataElement":{"publicId":"5612332","version":"1","preferredName":"Prostate Carcinoma TNM Stage Grouping Category","preferredDefinition":"Information related to the aggregated system of clinicopathologic evaluation of prostate cancer based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","longName":"5612319v1.0:5612316v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5612319","version":"1","preferredName":"Prostate Carcinoma TNM Stage Grouping","preferredDefinition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._Cancer that forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). Prostate cancer usually occurs in older men.","longName":"PROST_CA_TNM _STAG_GRP","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2744055","version":"1","preferredName":"Prostate Carcinoma","preferredDefinition":"Prostate carcinoma is one of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002","longName":"C4863","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B8AEEC8-FDF2-03F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-23","modifiedBy":"ONEDATA","dateModified":"2008-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2943789","version":"1","preferredName":"TNM Stage Grouping","preferredDefinition":"A system of clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment. (On-line Medical Dictionary):Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25384:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TNM Staging System","conceptCode":"C25384","definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741C2A5B-3981-C480-E040-BB89AD4371B5","latestVersionIndicator":"Yes","beginDate":"2009-09-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-21","modifiedBy":"ONEDATA","dateModified":"2009-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4533FADE-5600-7B40-E053-F662850A3056","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"MORENOC","dateModified":"2017-11-30","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5612316","version":"1","preferredName":"Prostate Carcinoma TNM Staging System Category","preferredDefinition":"Information related to the category of prostate cancer for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","longName":"PROST_CA_TNM_STAG_CATEGORY","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T1N0M0","valueDescription":"T1N0M0","ValueMeaning":{"publicId":"5612317","version":"1","preferredName":"T1N0M0","longName":"5612317","preferredDefinition":"T1N0M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4533D5DE-5019-6273-E053-F662850ADF31","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4533D5DE-5032-6273-E053-F662850ADF31","beginDate":"2017-01-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"ONEDATA","dateModified":"2017-01-03","deletedIndicator":"No"},{"value":"T2N0M0","valueDescription":"T2N0M0","ValueMeaning":{"publicId":"2943788","version":"1","preferredName":"T2N0M0","longName":"2943788","preferredDefinition":"T2N0M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741C2A5B-395B-C480-E040-BB89AD4371B5","latestVersionIndicator":"Yes","beginDate":"2009-09-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4533D5DE-503C-6273-E053-F662850ADF31","beginDate":"2009-09-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"ONEDATA","dateModified":"2017-01-03","deletedIndicator":"No"},{"value":"T3N0M0","valueDescription":"T3N0M0","ValueMeaning":{"publicId":"2943787","version":"1","preferredName":"T3N0M0","longName":"2943787","preferredDefinition":"T3N0M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741C2A5B-3938-C480-E040-BB89AD4371B5","latestVersionIndicator":"Yes","beginDate":"2009-09-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4533D5DE-5046-6273-E053-F662850ADF31","beginDate":"2009-09-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"ONEDATA","dateModified":"2017-01-03","deletedIndicator":"No"},{"value":"T3NxM0","valueDescription":"pT3 Stage Finding NX Stage Finding M0 Stage Finding","ValueMeaning":{"publicId":"6643146","version":"1","preferredName":"pT3 Stage Finding NX Stage Finding M0 Stage Finding","longName":"6643146","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT3 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 stage finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 stage finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.): A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT3 TNM Finding","conceptCode":"C48768","definition":"A pathologic primary tumor TNM finding. The definition of pT3 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M0 TNM Finding","conceptCode":"C48699","definition":"A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2DC4-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2DDD-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T2NxM0","valueDescription":"pT2 Stage Finding NX Stage Finding M0 Stage Finding","ValueMeaning":{"publicId":"6643147","version":"1","preferredName":"pT2 Stage Finding NX Stage Finding M0 Stage Finding","longName":"6643147","preferredDefinition":"A pathologic primary tumor TNM stage finding. The definition of pT2 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 stage finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 stage finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.): A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT2 TNM Finding","conceptCode":"C48764","definition":"A pathologic primary tumor TNM finding. The definition of pT2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M0 TNM Finding","conceptCode":"C48699","definition":"A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2DEB-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2E04-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T1NxM0","valueDescription":"pT1 Stage Finding NX Stage Finding M0 Stage Finding","ValueMeaning":{"publicId":"6643148","version":"1","preferredName":"pT1 Stage Finding NX Stage Finding M0 Stage Finding","longName":"6643148","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT1 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 stage finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.): A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT1 TNM Finding","conceptCode":"C48759","definition":"A pathologic primary tumor TNM finding.  The definition of pT1 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M0 TNM Finding","conceptCode":"C48699","definition":"A distant metastasis TNM finding indicating that there is no evidence of distant metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2E12-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2E2B-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T3N0Mx","valueDescription":"pT3 Stage Finding N0 Stage Finding MX Stage Finding","ValueMeaning":{"publicId":"6643149","version":"1","preferredName":"pT3 Stage Finding N0 Stage Finding MX Stage Finding","longName":"6643149","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT3 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 stage finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 stage finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.): A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT3 TNM Finding","conceptCode":"C48768","definition":"A pathologic primary tumor TNM finding. The definition of pT3 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MX TNM Finding","conceptCode":"C48704","definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2E39-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2E52-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T2N0Mx","valueDescription":"pT2 Stage Finding N0 Stage Finding MX Stage Finding","ValueMeaning":{"publicId":"6643150","version":"1","preferredName":"pT2 Stage Finding N0 Stage Finding MX Stage Finding","longName":"6643150","preferredDefinition":"A pathologic primary tumor TNM stage finding. The definition of pT2 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 stage finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 stage finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.): A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT2 TNM Finding","conceptCode":"C48764","definition":"A pathologic primary tumor TNM finding. The definition of pT2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MX TNM Finding","conceptCode":"C48704","definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2E60-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2E79-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T1N0Mx","valueDescription":"pT1 Stage Finding N0 Stage Finding MX Stage Finding","ValueMeaning":{"publicId":"6643151","version":"1","preferredName":"pT1 Stage Finding N0 Stage Finding MX Stage Finding","longName":"6643151","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT1 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 stage finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.): A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT1 TNM Finding","conceptCode":"C48759","definition":"A pathologic primary tumor TNM finding.  The definition of pT1 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MX TNM Finding","conceptCode":"C48704","definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2E87-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2EA0-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T3NxMx","valueDescription":"pT3 Stage Finding NX Stage Finding MX Stage Finding","ValueMeaning":{"publicId":"6643152","version":"1","preferredName":"pT3 Stage Finding NX Stage Finding MX Stage Finding","longName":"6643152","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT3 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 stage finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 stage finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.): A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT3 TNM Finding","conceptCode":"C48768","definition":"A pathologic primary tumor TNM finding. The definition of pT3 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MX TNM Finding","conceptCode":"C48704","definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2EAE-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2EC7-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T2NxMx","valueDescription":"pT2 Stage Finding NX Stage Finding MX Stage Finding","ValueMeaning":{"publicId":"6643153","version":"1","preferredName":"pT2 Stage Finding NX Stage Finding MX Stage Finding","longName":"6643153","preferredDefinition":"A pathologic primary tumor TNM stage finding. The definition of pT2 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 stage finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 stage finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.): A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT2 TNM Finding","conceptCode":"C48764","definition":"A pathologic primary tumor TNM finding. The definition of pT2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MX TNM Finding","conceptCode":"C48704","definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2ED5-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2EEE-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"},{"value":"T1NxMx","valueDescription":"pT1 Stage Finding NX Stage Finding MX Stage Finding","ValueMeaning":{"publicId":"6643154","version":"1","preferredName":"pT1 Stage Finding NX Stage Finding MX Stage Finding","longName":"6643154","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT1 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 stage finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.): A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT1 TNM Finding","conceptCode":"C48759","definition":"A pathologic primary tumor TNM finding.  The definition of pT1 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MX TNM Finding","conceptCode":"C48704","definition":"A distant metastasis TNM finding indicating that the status of distant metastasis cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D96411-2EFC-3154-E053-F662850A77D9","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81D96411-2F15-3154-E053-F662850A77D9","beginDate":"2019-02-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3432701","version":"1","preferredName":"TNM Stage","preferredDefinition":"A system of clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment. (On-line Medical Dictionary):The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C25384:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TNM Staging System","conceptCode":"C25384","definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCF27E5F-23D7-C93C-E040-BB89AD436034","latestVersionIndicator":"Yes","beginDate":"2012-04-05","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-04-05","modifiedBy":"ONEDATA","dateModified":"2012-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4533D5DE-5005-6273-E053-F662850ADF31","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"MORENOC","dateModified":"2019-02-14","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic Stage","type":"Preferred Question Text","description":"Pathologic Stage","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4533FADE-569E-7B40-E053-F662850A3056","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-01-03","modifiedBy":"MORENOC","dateModified":"2017-11-30","changeDescription":"11/30/2017: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}